Molecular profiling of p53 mutant endometrial cancer reveals distinct subgroups with opportunities for personalized therapeutic approaches

被引:0
|
作者
Blanc-Durand, F. [1 ]
Kramer, C. [2 ]
Rouleau, E. [3 ]
Vasseur, D. [4 ]
Bosse, T. [5 ]
de Boer, S. [6 ]
Edmondson, R. [7 ]
Powell, M. [8 ]
Crosbie, E. [9 ]
Singh, N. [10 ,11 ]
McAlpine, J. [12 ]
Mackay, H. [13 ]
Pollock, P. [14 ]
Mileshkin, L. [15 ]
Scott, C. L. [16 ]
Ngoi, N. Y. L. [17 ]
Lim, Y. W. [18 ]
Lim, S. E. [17 ]
Tan, D. S. [19 ]
Leary, A. [20 ]
机构
[1] Inst Gustave Roussy, Med Oncol Dept, Villejuif, France
[2] LUMC Leiden Univ, Pathol, Med Ctr, Leiden, Netherlands
[3] Gustave Roussy, Tumor Genet, Cancer Campus, Villejuif, France
[4] Gustave Roussy, Mol Biol, Canc Campus, Villejuif, France
[5] Leiden Univ, Pathol, Med Ctr, Leiden, Netherlands
[6] LUMC, Radiat Oncol, Univ Med Ctr, Leiden, Netherlands
[7] Univ Manchester, Div Canc Sci, Manchester, Lancs, England
[8] St Bartholomews Hosp, Med Oncol, London, England
[9] Univ Manchester, Med Oncol, Manchester, Lancs, England
[10] British Columbia Univ, Pathol, Vancouver Gen Hosp, Vancouver, BC, Canada
[11] Univ British Columbia, HSC, Vancouver, BC, Canada
[12] UBC Univ British Columbia, Med Oncol, Vancouver, BC, Canada
[13] Odette Canc Ctr, Med Oncol, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[14] Queensland Univ Technol, Med Oncol, Brisbane, Qld, Australia
[15] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia
[16] Walter & Eliza Hall Inst WEHI, Canc Biol & Stem Cells, Parkville, Vic, Australia
[17] Natl Univ Canc Inst Singapore, Dept Haematol Oncol, Singapore, Singapore
[18] NCIS Natl Univ Canc Inst Singapore, Singapore, Singapore
[19] NUHS Natl Univ Hlth Syst, Med Oncol Dept, Singapore, Singapore
[20] Inst Gustave Roussy, Med Dept, Villejuif, France
关键词
D O I
10.1016/j.annonc.2023.09.1966
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
788P
引用
收藏
页码:S529 / S530
页数:2
相关论文
共 50 条
  • [1] MOLECULAR PROFILING OF P53 MUTANT ENDOMETRIAL CANCER REVEALS DISTINCT SUBGROUPS WITH OPPORTUNITIES FOR PERSONALIZED THERAPEUTIC APPROACHES
    Blanc-Durand, Felix
    Kramer, Claire J. H.
    Rouleau, Etienne
    Vasseur, Antoine
    Bosse, Tjalling
    De Boer, Stephanie
    Edmondson, Richard
    Powell, Melanie
    Crosbie, Emma
    Singh, Naveena
    Mcalpine, Jessica
    Mackay, Helen
    Pollock, Pamela
    Mileshkin, Linda
    Scott, Clare
    Lim, Yi Wan
    Lim, Siew Eng
    Ngoi, Natalie Yan Li
    Tan, David
    Leary, Alexandra
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A44 - A44
  • [2] Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
    Muller, Patricia A. J.
    Vousden, Karen H.
    CANCER CELL, 2014, 25 (03) : 304 - 317
  • [3] Editorial: Mutant p53 in Cancer Progression and Personalized Therapeutic Treatments
    Timofeev, Oleg
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
    Xiaohua Chen
    Taotao Zhang
    Wei Su
    Zhihui Dou
    Dapeng Zhao
    Xiaodong Jin
    Huiwen Lei
    Jing Wang
    Xiaodong Xie
    Bo Cheng
    Qiang Li
    Hong Zhang
    Cuixia Di
    Cell Death & Disease, 13
  • [5] Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
    Chen, Xiaohua
    Zhang, Taotao
    Su, Wei
    Dou, Zhihui
    Zhao, Dapeng
    Jin, Xiaodong
    Lei, Huiwen
    Wang, Jing
    Xie, Xiaodong
    Cheng, Bo
    Li, Qiang
    Zhang, Hong
    Di, Cuixia
    CELL DEATH & DISEASE, 2022, 13 (11)
  • [6] Gain of Function (GOF) Mutant p53 in Cancer-Current Therapeutic Approaches
    Roszkowska, Katarzyna A.
    Piecuch, Aleksandra
    Sady, Maria
    Gajewski, Zdzislaw
    Flis, Sylwia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [7] Reactivation of mutant p53: molecular mechanisms and therapeutic potential
    Selivanova, G.
    Wiman, K. G.
    ONCOGENE, 2007, 26 (15) : 2243 - 2254
  • [8] Reactivation of mutant p53: molecular mechanisms and therapeutic potential
    G Selivanova
    K G Wiman
    Oncogene, 2007, 26 : 2243 - 2254
  • [9] Distinct tumor protein p53 mutants in breast cancer subgroups
    Dumay, Anne
    Feugeas, Jean-Paul
    Wittmer, Evelyne
    Lehmann-Che, Jacqueline
    Bertheau, Philippe
    Espie, Marc
    Plassa, Louis-Francois
    Cottu, Paul
    Marty, Michel
    Andre, Fabrice
    Sotiriou, Christos
    Pusztai, Lajos
    de The, Hugues
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (05) : 1227 - 1231
  • [10] Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches
    Alvarado-Ortiz, Eduardo
    de la Cruz-Lopez, Karen Griselda
    Becerril-Rico, Jared
    Sarabia-Sanchez, Miguel Angel
    Ortiz-Sanchez, Elizabeth
    Garcia-Carranca, Alejandro
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 8